Lung cancer drug resistance explained by computer simulations
(University of Bristol) Scientists from the Universities of Bristol and Parma, Italy, have used molecular simulations to understand resistance to osimertinib -- an anticancer drug used to treat types of lung cancer.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
More News: Cancer | Cancer & Oncology | Computers | International Medicine & Public Health | Italy Health | Lung Cancer | Universities